Personalized Oncology Workflow (Grade A)基于Claude AI的高级安全数据-人工智能技能，Grade A。结构化推理模板为AI辅助个体化mRNA肿瘤工作流。受2026罗志 Rosie mast细胞肿瘤病例的启发。物种感知

— (0)

审阅者 Daniel Nikulshyn·更新 2026年7月

概览

个体化肿瘤工作流是结构化推理模板，设计用于AI辅助个体化mRNA肿瘤工作流。它受到2026罗志 Rosie mast细胞肿瘤病例的启发，并专门考虑到物种感知和安全性首位，需要Veterinary Oncologist 监督。这项工作流引导个体化mRNA基因表达的分析和计划，适用于中晚期或抗药性腺瘤病例。它提供了依据证据优先的步骤，评估可行性、所需数据、关键AI/研究人员交点和关键安全/ 警示检查点。这不是替代Veterinary Oncologist 审核和监管。

主要功能

品种特异性mast细胞肿瘤生物学
Neo抗原识别原理
与AI工具（如ChatGPT/Claude/Gemini、AlphaFold和自定义ML）集成
依据权威Veterinary 资源提供指导

价格

模型: Free
分类: 育言活动
评分: 暂无评价

使用场景

优点 & 缺点

优点

提供结构化的个体化mRNA肿瘤工作流
物种感知和安全性首位的设计
为安全性和专业知识追加安全性和Veterinary Oncologist 监督
基于实际案例（2026 Rosie mast细胞肿瘤病例）进行了实用相关的启发
依据特定品种进行调整
依据特定情况调整

缺点

不适合常规淋巴瘤协议、首次治疗规划或非肿瘤病例
要求肿瘤序列数据（WES/RNA - seq），在某些情况下可能不可用或不可行
仅限于犬和猫，须谨慎用于非犬品种

评测

登录以留下评测。

暂无评测。来当第一个吧!

问答

Can this workflow be used for routine lymphoma treatment plans?

No, it is intended for advanced or refractory neoplasia cases and is not suitable for standard lymphoma protocols or first‑line therapy planning.

Asked by Vasyl Kovalenko · Aug 30, 2025

Is veterinary oncologist oversight required when using this tool?

Absolutely; the workflow is safety‑first and mandates board‑certified veterinary oncologist review and regulatory oversight; it is not a substitute for professional judgment.

Asked by Umar Farooq · Jul 28, 2025

Do I need tumor sequencing data to use this workflow?

Yes, the workflow requires whole-exome or RNA sequencing data from the tumor to evaluate neoantigen identification and feasibility of personalized mRNA approaches.

Asked by Jovana Petrovic · Jul 6, 2025

What species does the Personalized Oncology Workflow support?

The workflow is species-aware and is designed specifically for dogs and cats, with caution advised for any non-canine species.

Asked by Xavier Costa · Jun 24, 2025